山东大学学报 (医学版) ›› 2022, Vol. 60 ›› Issue (7): 123-128.doi: 10.6040/j.issn.1671-7554.0.2021.1347
李宏文1,周子芙1,王耸1,霍然1,2
LI Hongwen1, ZHOU Zifu1, WANG Song1, HUO Ran1,2
摘要: 目的 从临床及卫生经济学的角度评价儿童面部先天性色素痣一期切除手术和分期切除手术的效果,并进行成本-效果分析。 方法 回顾性分析2018年6月至2019年6月就诊于山东省立医院整形美容外科的面部先天性色素痣患儿的临床资料58例,按照手术方式将患儿分成一期切除组(30例)和分期切除组(28例)。收集术后6个月刀口瘢痕的长度、宽度和面积以评估手术效果,收集两组的直接成本和间接成本。应用增量成本效果比值(ICER)进行成本-效果分析。 结果 两组患者均顺利完成手术,一期切除组和分期切除组所产生的总治疗成本分别为7 824.52(6 620.51,8 445.64)元和14 769.99(13 971.52,14 769.99)元,分期切除组明显高于一期切除组(P<0.001)。术后瘢痕面积与术前色素痣面积相比,一期切除组减少0.29(0.10,0.79)cm2,分期切除组减少0.95(0.29,2.59)cm2,分期切除组明显高于一期切除组(P=0.02)。增量成本效果分析显示,一期切除组患者病损面积每减少1 cm2需花费26 981.10元,分期切除组病损面积每减少1 cm2需花费15 547.36元。 结论 分期切除面部先天性色素痣相比于一期切除,术后不额外增加瘢痕长度,而且在处理较宽的病损时,也不增加瘢痕宽度。分期切除虽然会给患者增加额外的成本,但是分期切除仍是一种ICER更优的手术治疗色素痣的方案。
中图分类号:
[1] Krengel S, Scope A, Dusza SW, et al. New recommendations for the categorization of cutaneous features of congenital melanocytic nevi[J]. J Am Acad Dermatol, 2013, 68(3): 441-451. [2] Krengel S, Hauschild A, Schäfer T. Melanoma risk in congenital melanocytic naevi: a systematic review[J]. Br J Dermatol, 2006, 155(1): 1-8. [3] Masnari O, Schiestl C, Rössler J, et al. Stigmatization predicts psychological adjustment and quality of life in children and adolescents with a facial difference[J]. J Pediatr Psychol, 2013, 38(2): 162-172. [4] Neuhaus K, Landolt M, Vojvodic M, et al. Surgical treatment of children and youth with congenital melanocytic nevi: self- and proxy-reported opinions[J]. Pediatr Surg Int, 2020, 36(4): 501-512. [5] 周子芙,张瑾,王耸,等.78例儿童先天性面部色素痣分期切除结合外扩张的美容效果[J].山东大学学报(医学版), 2021, 59(2): 71-75. ZHOU Zifu, ZHANG Jin, WANG Song, et al. Cosmetic effects of staged resection of congenital facial nevus combined with external dilatation in 78 children [J]. Journal of Shandong University(Health Sciences), 2021, 59(2): 71-75. [6] Ott H, Krengel S, Beck O, et al. Multidisciplinary long-term care and modern surgical treatment of congenital melanocytic nevi—recommendations by the CMN surgery network[J]. J Dtsch Dermatol Ges, 2019, 17(10): 1005-1016. [7] Arad E, Zuker RM. The shifting paradigm in the management of giant congenital melanocytic nevi: review and clinical applications[J]. Plast Reconstr Surg, 2014, 133(2): 367-376. [8] Liu H, Yu N, Shi J, et al. A new modified S-plasty for skin defect closure[J]. Aesthetic Plast Surg, 2015, 39(1): 100-105. [9] Iida N, Watanabe A, Kusano T. Usefulness of S-shaped incision in large nevus sequential excision[J]. Plast Reconstr Surg Glob Open, 2014, 2(10): e224. [10] Mutti LdA, Mascarenhas MRM, Paiva JMGd, et al. Giant congenital melanocytic nevi: 40 years of experience with the serial excision technique[J]. An Bras Dermatol, 2017, 92(2): 256-259. [11] Sanders GD, Neumann PJ, Basu A, et al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine[J]. JAMA, 2016, 316(10): 1093-1103. [12] Sanders GD, Maciejewski ML, Basu A. Overview of cost-effectiveness analysis[J]. JAMA, 2019, 321(14): 1400-1401. [13] OMahony JF. Does cost-effectiveness analysis really need to abandon the incremental cost-effectiveness ratio to embrace net benefit?[J]. Pharmacoeconomics, 2020, 38(8): 777-779. [14] Leshem D, Gur E, Meilik B, et al. Treatment of congenital facial nevi[J]. J Craniofac Surg, 2005, 16(5): 897-903. [15] 祁方家,卢建龙,冯莎,等.药物经济学评价中常见的成本及其测算方法[J].上海医药, 2015, 36(1): 7-9, 13. QI Fangjia, LU Jianlong, FENG Sha, et al. Common costs and their estimation methods in pharmacoeconomics [J]. Shanghai Medical & Pharmaceutical Journal, 2015, 36(1): 7-9, 13. [16] Breuninger H, Häfner HM. Serial excision with power stretching for large and giant melanocytic nevi of the trunk[J]. J Dtsch Dermatol Ges, 2019, 17(8): 852-855. [17] 顾子春,李华,叶学红,等.分次切除在皮肤病损治疗中的应用价值[J].全科医学临床与教育, 2007, 5(2): 119-121. GU Zichun, LI Hua, YE Xuehong, et al. The application value of fractional resection in treatment of skin lesion [J]. Clinical Education of General Practice, 2007, 5(2): 119-121. [18] Lim JM, Oh Y, Lee SH, et al. Comparison of treatment options for small to medium congenital melanocytic nevi: a retrospective review of 119 cases[J]. Lasers Surg Med, 2019, 51(1): 62-67. [19] Fahradyan A, Wolfswinkel EM, Tsuha M, et al. Cosmetically challenging congenital melanocytic nevi[J]. Ann Plast Surg, 2019, 82(5S Suppl 4): S306-S309. [20] Hassanein AH, Rogers GF, Greene AK. Management of challenging congenital melanocytic nevi: outcomes study of serial excision[J]. J Pediatr Surg, 2015, 50(4): 613-616. [21] 王振宇,逯艳,余睿芳,等.鱼嘴形切口在色素痣分次手术切除中的临床应用[J].中国美容医学, 2019, 28(4): 125-127. WANG Zhenyu, LU Yan, YU Ruifang, et al. The clinical application of fish-mouth shaped incision used in fractional surgical resection of pigmented nevus [J]. Chinese Journal of Aesthetic Medicine, 2019, 28(4): 125-127. [22] Fife DJ, Alam M. Alternative techniques for reduction of scar length during staged excision[J]. J Am Acad Dermatol, 2011, 65(4): 811-818. [23] Neumann PJ, Sanders GD. Cost-effectiveness analysis 2.0[J]. N Engl J Med, 2017, 376(3): 203-205. [24] 张楠,石学峰,吴晶.增量成本效果比在卫生技术评估中的应用[J].中国卫生政策研究, 2012, 5(2): 64-68. ZHANG Nan, SHI Xuefeng, WU Jing. The application of incremental cost-effectiveness ratio to health technology assessment [J]. Chinese Journal of Health Policy, 2012, 5(2): 64-68. [25] 陈英耀,董恒进,吕军,等.临床经济学概述[J].中华医院管理杂志, 2000, 16(6): 54-56. |
[1] | 董雪,赵霞,程子捷,韩毅. 左西孟旦和米力农治疗重症心力衰竭合并肾损伤患者711例的药物经济学评价[J]. 山东大学学报 (医学版), 2022, 60(4): 91-98. |
[2] | 周子芙,张瑾,王耸,李志宇,冶小云,毕见海,徐广琪,张健,吕仁荣,霍然. 78例儿童先天性面部色素痣分期切除结合外扩张的美容效果[J]. 山东大学学报 (医学版), 2021, 59(2): 71-75. |
|